These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30633811)

  • 21. A Colocalized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence Population.
    Adamson PC; Miceli J; Shiferaw B; Villanueva MS; Canterino JE
    Am J Med; 2020 Jun; 133(6):705-712. PubMed ID: 31987799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care.
    Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Bollipo S; McGarity B; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK
    J Gastroenterol Hepatol; 2024 Mar; 39(3):568-575. PubMed ID: 38114452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
    Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
    J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.
    Roberson JL; Lagasca AM; Kan VL
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):148-155. PubMed ID: 28974107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
    Mehta SH; Lucas GM; Mirel LB; Torbenson M; Higgins Y; Moore RD; Thomas DL; Sulkowski MS
    AIDS; 2006 Nov; 20(18):2361-9. PubMed ID: 17117023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    Amele S; Peters L; Sluzhynska M; Yakovlev A; Scherrer A; Domingo P; Gerstoft J; Viard JP; Gisinger M; Flisiak R; Bhaghani S; Ristola M; Leen C; Jablonowska E; Wandeler G; Stellbrink H; Falconer K; D'Arminio Monforte A; Horban A; Rockstroh JK; Lundgren JD; Mocroft A;
    HIV Med; 2019 Apr; 20(4):264-273. PubMed ID: 30734998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row.
    Benitez TM; Fernando SM; Amini C; Saab S
    Dig Dis Sci; 2020 Oct; 65(10):3023-3031. PubMed ID: 31974916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
    Downes JM; Donovan A; McAdam-Marx C
    J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.
    Foster MA; Xing J; Moorman AC; Boscarino J; Gordon SC; Lu M; Rupp L; Schmidt MA; Trinacty CM; Xu F; Holmberg SD; Spradling PR
    Dig Dis Sci; 2016 Dec; 61(12):3469-3477. PubMed ID: 27510752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial.
    Morris MD; McDonell C; Luetkemeyer AF; Thawley R; McKinney J; Price JC
    JAMA Netw Open; 2023 Oct; 6(10):e2338792. PubMed ID: 37862013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
    Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
    Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
    Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
    Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals.
    Simmons R; Ireland G; Irving W; Hickman M; Sabin C; Ijaz S; Ramsay M; Lattimore S; Mandal S
    J Viral Hepat; 2018 May; 25(5):482-490. PubMed ID: 29239130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
    Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
    Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care setting.
    Manos MM; Darbinian J; Rubin J; Ray GT; Shvachko V; Denis B; Velez F; Quesenberry C
    J Manag Care Pharm; 2013; 19(6):438-47. PubMed ID: 23806057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Care Providers in Federally Qualified Health Centers Can Treat Hepatitis C Effectively Without Ongoing Consultative Support From Specialists.
    Moore RA; Fried MW; Wright B
    Med Care; 2021 Aug; 59(8):699-703. PubMed ID: 34081677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative.
    Ramirez G; Cabral R; Patterson M; Schoenbachler BT; Bedell D; Smith BD; Vellozzi C; Beckett GA
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):5-11. PubMed ID: 27168655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.